Recent Finacing
Recent Raise
Constellation Pharmaceuticals is a Cambridge-based clinical-stage biopharma that discovers and develops small-molecule epigenetic inhibitors targeting chromatin regulators (BET, EZH2) and advances oncology clinical programs including CPI-0610 and CPI-1205.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
